Background: Histone deacetylase (HDAC) 8 is one of its family members catalyzes the removal of acetyl groups from N-terminal lysine residues of histone proteins thereby restricts transcription factors from being expressed. Inhibition of HDAC8 has become an emerging and effective anti-cancer therapy for various cancers. Application computational methodologies may result in identifying the key components that can be used in developing future potent HDAC8 inhibitors.
INTRODUCTION
Histone deacetylases (HDACs) are a family of enzymes catalyzes the deacetylation mechanism using either a divalent metal cation (Zn 2+ ) or a cofactor (NAD + ) 1, 2 . Based on these catalytic machineries, this family of HDAC enzymes was classified into two major categories, namely, zinc-dependent and NAD-dependent HDAC enzymes. The NAD-dependent HDAC enzymes are also widely known as sirtuins. Further, zinc-dependent HDAC enzymes were classified into three classes, namely, Class I, II, and IV based on their structures and domain organization whereas sirtuins form Class III HDACs. The class I (HDACs 1-3 and 8) HDACs are homologous to the yeast Rpd3 deacetylase; class II (HDACs 4-7, 9 and 10) HDACs are related to the yeast Hda1 deacetylase; and class III proteins, sirtuins, are yeast Sir2 homologues. HDAC11 has homology to both class I and class II enzymes but is classified as class IV enzyme. Class I and class II HDACs, as well as HDAC11 are zinc-dependent hydrolases whereas class III sirtuins are NAD-dependent enzymes.
These HDAC enzymes are implicated in a wide variety of biological processes such as apoptosis, differentiation, proliferation, and senescence 3 . Because of these widespread biological effects, inhibition of these enzymes provides a new therapeutic approach for many diseases, including neurodegenerative, hereditary, inflammatory diseases and cancer [4] [5] [6] [7] [8] [9] [10] [11] . The HDAC enzymes are found in bacteria, fungi, plants, and animals whereas HATs are present only in eukaryotic systems 12, 13 . The HDAC family of enzymes majorly deacetylates epsilon amino groups of N-terminal lysine residues present in histone proteins 14 . A few other target proteins such as p53, E2F, and a-tubulin were also identified and reported to be deacetylated by HDAC enzymes 3 . Acetylation is a post-translational modification that is regulated by HDACs and a family of functionally opposite histone acetyl transferase (HAT) enzymes 15, 16 . During the process of deacetylation the positive charge density of lysine residues of the N-termini of histones is restored which leads to the tightbinding of histone and DNA carrying negative charge. This tight histone-DNA binding restricts the access of transcription factors and this is balanced by HATs that loosen the binding with the addition of acetyl groups to mask the positive charge of Ntermini of histone proteins 17 . The catalytic functions of these two enzymes are well balanced in normal cells, but the disturbance of this balance is frequently observed in human cancers [18] [19] [20] . In addition to cancer, other therapeutic applications on neurodegenerative diseases and inflammation have been proposed for HDAC inhibitors 21 . Classes I and IV HDACs are ubiquitously expressed, predominantly in the nucleus, and function mainly as transcriptional co-repressors that are linked to cell proliferation and survival 22 . The distribution of class II HDACs, which are able to shuttle in and out of the nucleus, is more tissue specific, suggesting distinct functions in cellular differentiation and developmental processes 23 . Blocking the activity of HDAC enzymes should favor chromatin relaxation and increase gene transcription, which could be a common mechanism for the induction of gene expression by HDAC inhibitors 15 . HDAC inhibitors are structurally distinct, comprising hydroxamic acids, cyclic peptides, electrophilic ketones, shortchain fatty acids, and benzamides [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Three structural characteristics are commonly present in all HDAC inhibitors: a metalbinding moiety (MBM) to coordinate the catalytic metal ion, and a hydrophobic spacer (HYS) and hydrophobic cap (HYC) group to bind with residues at the tunnel and active site entrance, respectively (Figure 1 ). Among the various classes of HDAC inhibitors, hydroxamic acid inhibitors are the most wellstudied group and includes Vorinostat (Suberoanilide hydroxamic acid, SAHA), which was recently approved by FDA for the treatment of cutaneous T-cell lymphoma. A handful of molecules from this class are in various phases of drug development. Panobinostat, Belinostat, ITF-2357 are some of the hydroxamic acid derivatives in phase II development. Several other inhibitors, MS-275 and MGCD0103 (benzamide), depsipeptide (cyclic peptide), and valproic acid and butyrate (short-chain fatty acid), are also in active development 35 . Almost 30 years ago, some studies to understand the effect of dimethyl sulfoxide on terminal differentiation of murine erythroleukemia cells 36 led to the development of novel pharmacological agents in the area of chromatin remodeling. The HDAC enzymes possess a narrow and deep active site spanning a length equivalent to four or six straight carbon chains. A divalent cation (Zn 2+ ) is located at the bottom of the active site and acts as catalytic machinery in combination with charge relay system residues H142, H143, D176 and D183 14 . Except HDAC8, functional HDACs are not found as single peptides but as multimeric complexes of higher molecular weight and also most of the purified HDAC enzymes are functionally inactive 37, 38 . Along with this advantage, expression of HDAC8 notably correlates with the disease stage of neuroblastoma, a highly malignant childhood cancer derived from the sympathetic nervous system 39, 40 . Moreover, an RNA interfer- ence study showed that HDAC8 is involved in the regulation of proliferation, clonogenic growth and neuronal differentiation of neuroblastoma cells. Inv1, an abnormal fusion protein formed during acute myeloid leukemia binds HDAC8, is also associated with aberrant, constitutive genetic repression 41 . Therefore, HDAC8 is considered to be the best model among other mammalian HDACs from a structural biology and drug discovery perspective.
Including our recent research studies 3, 14 there are few ligandand structure-based drug designing approaches using various computational methodologies were performed to identify novel chemical scaffolds for the future HDAC8 inhibitor design. In this study, we focused on identifying the physicochemical properties and the favorable molecular fragments of the known inhibitors that influence the biological response of HDAC8 inhibition. Thus the results of this study can be utilized as a starting point in designing future HDAC8 inhibitors from the medicinal chemistry perspective.
RESULTS AND DISCUSSION

QSAR models
Two types of QSAR models using genetic function approximation (GFA) and Bayesian statistical algorithms were developed using the lowest energy conformations of same training set of 30 compounds (Table 1) , after removing the molecular descriptors with zero or constant values. All training set compounds possess the generally accepted pharmacophoric features of HDAC inhibitors. This includes a MBM to interact the divalent metal ion, a HYC to bind the surface forming residues, and a HYS linking them 14 . All HDAC enzymes possess a tunnel-like active site with catalytic machinery containing a divalent cation (Zn 2+ ) along with a charge relay system composed of two histidine and two aspartate residues 3, 14 . All training set compounds used in this study contains all of these three pharmacophoric features to effectively bind the tunnel-like active site. The MBM moieties of these training set compounds vary among hydroxamic acid, thioacetic acid, hydroxyformamide, and substituted amides.
Genetic function approximation (GFA) models
The GFA models were built using the pIC50 values and 2D and 3D physicochemical properties of ligands as molecular descriptors. The pIC50 values of compounds were considered as the dependent variable and the molecular descriptors as independent variables. The models were generated and optimized by reducing the descriptors using GFA. Six models out of ten generated models were considered statistically significant as they were developed with six molecular descriptors whereas the other four models were of more than six descriptors. Since the training set was composed of 30 chemical compounds it is significant to develop a model with a maximum of six descriptors. The reduced set of molecular descriptors used in model development contained 11 molecular descriptors (Table 2) including connectivity indices, charged polar surface area descriptors, alpha-modified shape index of order one, and number of hydrogen bond donors. From the six QSAR models that were developed with six molecular descriptors, top two models were selected as best models based on the statistical parameters calculated during model generation and the prediction over an external test set ( Table 4 ). The four 2D descriptors that involved in model 1 contained three topological descriptors and number of hydrogen bond donors whereas the two 3D descriptors were charged surface area descriptors (Table 4) . From the equation of model 1, it was observed that four descriptors, namely, Num_H_Donors, CHI_V_1, Jurs_ DPSA_1, and Jurs_RPCS have shown negative contribution to the biological activity of the HDAC8 inhibitors. However, CHI_ V_3_P and Kappa_1_AM have shown positive effect on the biological activity. In detail, the chemical compounds designed to have higher amount of positively correlating and lesser amount of negatively correlating physicochemical properties can be a reliable set of potential HDAC8 inhibitors. The correlation between experimental and predicted biological activity values is represented as r 2 values and the plot between these values is displayed in Figure 2A . The model 1 has predicted the experimental activities of the training set compounds accurately and none of the residual values was higher than 0.684 (Table 5) .
The model 2 also was developed with similar statistical parameters and molecular descriptors during the development of models. The r Table 3 ). The molecular descriptors in- volved in the model development were Num_H_Donors, CHI_ V_1, CHI_V_3_P, Kappa_1_AM, Jurs_FNSA_1, and Jurs_RPCS. This model also is a hybrid model including four 2D and two 3D descriptors (Table 4 ). The adj-r 2 value of model 2 indicates that the model can explain 81.3% of the variance whereas its q 2 value shows the 73.4% predictive variance of the model 2. In terms of the individual contribution by the molecular descriptors, Num_H_Donors, CHI_V_1, and Jurs_RPCS have contributed negatively whereas CHI_V_3_P, Kappa_1_AM, and Jurs_ FNSA_1 have shown positive effect over the biological response (pIC50). In detail, the chemical compounds designed to have higher amount of positively correlating and lesser amount of negatively correlating physicochemical properties can be a reliable set of potential HDAC8 inhibitors. The correlation between experimental and predicted biological activity values is represented as r 2 value and the plot between these values obtained from model 2 is displayed in Figure 2B . The model 2 has predicted the experimental activities of the training set compounds accurately and none of the residual values was higher than 0.694 (Table 5 ). The calculated values of molecular descriptors used in the development of model 1 and model 2 are given in Table 6 . As a validation procedure, an external test set containing 54 compounds not used in developing QSAR models was used to ensure the predictive ability of the generated models. Model 1 and 2 have shown high correlation coefficient values in this test set validation (Figure 3) . The residual values calculated from the experimental and predicted pIC50 values of test set compounds were not higher than 1 which indicated the high accuracy in test set prediction (Table 7) . Four other GFA models have shown less accuracy in test set prediction and not considered as the significant outcome of this study (Table 3) .
Bayesian model development
The Bayesian model concepts exist for many years but their applications in the area of drug discovery and structure-activity relationship are recent. This approach uses a machine learning Surface-weighted charged partial surface areas 3D Kappa_1_AM
Alpha-modified shape index of order one 2D Num_H_Donors Hydrogen bond donors are defined as heteroatoms (oxygen, nitrogen, sulfur, or phosphorus) with one or more attached hydrogen atoms. Table 3 . Statistical descriptions of the developed models A B method with two-dimensional descriptors to distinguish between compounds that are HDAC8 inhibitors and non-inhibitors. A Bayesian model was generated with 30 training set compounds using molecular finger prints of maximum diameter 6 (ECFP_6) and eight interpretable descriptors. The developed model was observed with a receiver operator characteristic (ROC) curve statistic value for leave-one-out cross validation of 0.920 and the best split value was 1.106 (Table 8 and Figure 4) . Utilization of ECFP_6 descriptors in the study has identified the substructure descriptors that have shown favorable and unfavorable contributions to HDAC8 inhibition. Supplementary Table 1 displays the prediction of training set compounds based on the developed Bayesian model. In addition to the ROC statistic value, the external test set containing 54 compounds was used to investigate the ability in classifying the chemical compounds. Nine out of 14 compounds in the test set with the IC50 values of less than or equal to 1.5 µM were classified as HDAC8 inhibitors. Interestingly, 39 out of 40 compounds were correctly classified as non-inhibitors indicating the high prediction (Supplementary Table 2 ). As the Bayesian model with ECFP_6 fingerprint descriptors were used in model generation, visualization of substructure fingerprints that contributed positively and negatively to the activity classification was possible. It was observed that highly hydrophobic thiophenyl and thiazole heterocyclic rings along with metal binding hydroxamic acid and amide moieties have contributed positively. In the other hand, pyrrole, indole, and aliphatic long chain spacers have contributed negatively ( Figure 5 , Supplementary Figure 1 , and Supplementary Figure 2 ). This comparison of positively and negatively contributing molecular fingerprints of the HDAC8 inhibitors has 
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CONCLUSION
In order to identify important physicochemical properties and molecular fragments those influence the HDAC8 inhibition GFA and Bayesian models were developed using a training set containing 30 HDAC8 inhibitors. The training set compounds used in the development of models comprised a diverse set of compounds that possess the general pharmacophore of HDAC inhibitors, which includes MBM, HYS, and HYC moieties. The MBM moiety present in the training set compounds ranged from hydroxamic acid derivatives to amide moieties. At the same time, HYS and HYC moieties also varied from long alkyl chains to bulky aromatic groups. Numbers of GFA models were developed with different set of parameters available in DS. A set of six GFA models were developed with six molecular descriptors while others were with more than six and statistically insignificant. Finally, two GFA models were selected based on test set predictive ability from six statistically significant models. The r 2 , q 2 , and LOF values of both the models were very similar and the r 2 values of test set prediction were 0.505 and 0.515, respec- revealed that highly hydrophobic moieties are important in binding the tunnel and surface forming residues and the bulky hydrophobic substituents are preferred over alkyl long chain moieties. In addition, any one of the metal binding moieties present in the training set compounds is necessary for effective HDAC8 inhibition.
tively. The Bayesian model developed using the same training set compounds has shown a ROC cross-validation value of 0.902. Since this model was developed using ECFP_6 fingerprints descriptors, we could identify the molecular fingerprints that influenced the biological response negatively and/or positively. This model has also classified the external test set containing 54 compounds with high accuracy, which indicated its robustness in classifying HDAC8 inhibitors. The hydrophobic molecular fragments including thiophenyl and thiazole heterocyclic rings have shown positive contribution whereas the long chain alkyl and pyrrole moieties of hydrophobic nature have contributed negatively to the classification. In terms of various MBMs, hydroxamic acid and amide derivatives have shown positive effects in the model. The physicochemical properties and the molecular fingerprints identified from this study to contribute substantially for the biological response i.e. HDAC8 inhibition can provide deeper insight in designing future HDAC8 inhibitors with added potency.
MATERIALS AND METHODS
Collection of HDAC8 inhibitors
A total of more than 500 compounds were collected from various literature resources including patents. Among these, 84 compounds with HDAC8 inhibitory activity values predicted under same biological assay conditions were selected to be used in QSAR model generation and validation [42] [43] [44] [45] [46] [47] [48] . The inhibitory activity values of these compounds were calculated in IC50 values which were converted to -logarithmic (-logIC50 or pIC50) scale to be utilized in this study The Find Diverse Ligands protocol implemented in Accelrys Discovery Studio 2.5 (DS) (Accelrys Inc., San Diego, USA) was employed to select diverse compounds from the pool of collected HDAC8 inhibitors. The data set was finally divided into training and test sets containing 30 and 54 compounds, respectively. The 30 training set compounds that are chemically diverse and with the IC50 values ranging from 0.01 to 35 µM were used in the development of QSAR models ( Table 1) .
Preparation of chemical compounds
All the compounds in the dataset were sketched using Chemsketch, version 12 program (Advanced Chemistry Development Inc., Toronto, Canada) and subsequently converted to 3D struc- tures using DS program. These compounds were then subjected to energy minimization using CHARMM force field 49 to generate the lowest energy conformation of every compound under study. The Smart Minimizer option that performs 1,000 steps of Steepest Descent with a RMS gradient tolerance of 3, followed by Conjugate Gradient minimization was used with a RMS gradient of 0.1 kcal/(mol × Å). This minimization option is particularly recommended when the minimization is starting from a very poor conformation. All the minimized compounds were considered in the next step of calculating the molecular descriptors.
Descriptors calculation and selection
Descriptor is nothing but a molecular property of a chemical compound. There are huge set of molecular descriptors were identified and can be calculated using various computational programs. For instance, a descriptor calculating program known as DRAGON can calculate more than 3,000 molecular descriptors for a chemical compound 50 . Though we can calculate thousands of descriptors, it is only useful in medicinal chemistry perspective when they are reduced to a few set of molecular descriptors that can effectively be applied in designing novel and potent compounds. Thus the main goal of a QSAR study is not to calculate thousands of descriptors but to identify a few molecular descriptors explaining the biological activities of the known drug molecules. In this study, we have calculated a set of 2D and 3D descriptors using Calculate Molecular Properties protocol as available in DS. The 2D descriptors included AlogP, molecular property counts, surface are and volume, and topological descriptors whereas the 3D descriptors included dipole and Jurs descriptors. The Jurs descriptors combine shape and electronic information to characterize the molecules and it is calculated by mapping atomic partial charges on solvent-accessible surface areas of individual atoms. The molecular descriptors with a zero or constant value for all the compounds in the dataset and with a correlation co-efficient value less than 0.3 against the pIC50 value, which is the dependent variable, were removed and not included in the study. The training set compounds along with their pIC50 values and calculated molecular descriptors were considered in the development of QSAR models.
Development of QSAR models and validation
The QSAR models were generated using GFA and Bayesian algorithms with the same training set compounds. Recently, GFA technique is used extensively in the system of a small quantity of samples with large set of descriptors, where the selection of descriptors is difficult 51, 52 . The GFA applies the concept of evolution via natural selection 53 . This method generates a series of potential solutions to a problem and then these solutions are modified and tested repeatedly until an approximate optimal solution is found 54 . Only a subset of statistically significant molecular descriptors in terms of correlation with the biological activity values was selected in GFA calculations. The Create Genetic Function Approximation model protocol as available in DS was used to optimize the QSAR models and some parameters with minor contributions to the QSAR were omitted to get the optimized set of descriptors. This software also provides various scoring functions such as Friedman LOF, r 2 , adj-r 2 , and q 2 values to evaluate the quality of the obtained equations. Since only 30 compounds were used in QSAR model construction and too many descriptors will make the obtained model lose statistical significance, the number of descriptors tried in the subset was confined from 2 to 6. This selection also obeyed a rule of selecting one descriptor for five compounds in model development.
In case of Bayesian model generation, fingerprint descriptors were also included to find out the favorable and non-favorable molecular fragments that influence the biological activities positively and negatively. The same training set compound used in developing GFA models was employed in the Bayesian model generation as well. The compounds in the training set were divided into active and inactive based on their IC50 values. The ECFP_6 and eight interpretable descriptors including AlogP, molecular weight, rotatable bonds, number of rings, number of aromatic rings, hydrogen bond acceptor, hydrogen bond donor, and polar surface area were used in generating a model with a ROC statistic. A significant QSAR model should be capable of predicting the biological activities of new ligands. Thus, the generated QSAR models were validated based on the statistical parameters such as LOF and r 2 calculated during the model generation and also using an external test set containing diverse compounds.
